|Articles|November 20, 2017

EMA to Relocate to Amsterdam, The Netherlands

The long waited news of where the EMA will be relocated to due to the United Kingdom’s decision to withdraw from the EU has finally been revealed today. The European Medicines Agency will relocate to Amsterdam in the Netherlands just in time for the move in March of 2019.

Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

EMA to Relocate to Amsterdam, The Netherlands

Related Content

Two New Partnerships Aim to Expand Patient Access to Clinical Trials Through Community-Based Research

Where Capability Gaps Hide When Scientific Intent Doesn't Translate Into Operations

ACT Brief: Product Development Assumptions, Portfolio-Level Recruitment Infrastructure, and Risk-Based Quality Integration

From Study-by-Study to Portfolio Recruitment: Q&A with Gaynor Anders, Trialbee

Why Execution Strategy Begins at the Business Decision, Not Study Startup

Trending on Applied Clinical Trials Online

Two New Partnerships Aim to Expand Patient Access to Clinical Trials Through Community-Based Research

From Study-by-Study to Portfolio Recruitment: Q&A with Gaynor Anders, Trialbee

ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN

ACT Brief: Sponsor Accountability in Outsourcing, Biomarker Strategy in Precision Oncology, and Novel Sciatica Therapy

Precision Oncology Trials Need to Reflect the Complexity of Cancer Biology